Deksametazon Sandoz 4 mg/ml otopina za injekciju
| Name | Deksametazon Sandoz 4 mg/ml otopina za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-499072469 |
| Active Substance | natrijev deksametazonfosfat |
| Composition | jedna ampula s 1 ml otopine za injekciju sadrži 4 mg deksametazonfosfata u obliku natrijevog deksametazonfosfata |
| Pharmaceutical Form | otopina za injekciju |
| Manufacturer | Salutas Pharma GmbH, Barleben, Njemačka Ever Pharma Jena GmbH, Jena, Njemačka Sandoz GmbH, Kundl, Austrija Ever Pharma Jena GmbH, Jena, Njemačka Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 17.06.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/633 |
| Registration Number | 381-12-01/70-19-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | H02AB02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |